Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ $177.40)
- $177.40 P/E (TTM): 19.04X Cap: $427.23B
- View JNJ Profile
- View Questions on JNJ

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Amgen Inc. (AMGN $274.40)
- $274.40 P/E (TTM): 22.58X Cap: $147.72B
- View AMGN Profile
- View Questions on AMGN
Gilead Sciences Inc. (GILD $112.54)
- $112.54 P/E (TTM): 22.77X Cap: $141.15B
- View GILD Profile
- View Questions on GILD
AbbVie Inc. (ABBV $217.61)
- $217.61 P/E (TTM): 104.47X Cap: $385.71B
- View ABBV Profile
- View Questions on ABBV
Abbott Laboratories (ABT $131.33)
- $131.33 P/E (TTM): 16.78X Cap: $232.75B
- View ABT Profile
- View Questions on ABT
The Cigna Group (CI $297.14)
- $297.14 P/E (TTM): 16.64X Cap: $80.81B
- View CI Profile
- View Questions on CI
Johnson & Johnson (JNJ $177.40)
- $177.40 P/E (TTM): 19.04X Cap: $427.23B
- View JNJ Profile
- View Questions on JNJ
Medtronic plc. (MDT $93.43)
- $93.43 P/E (TTM): 26.05X Cap: $119.84B
- View MDT Profile
- View Questions on MDT
Savaria Corporation (SIS $20.78)
- $20.78 P/E (TTM): 26.64X Cap: $1.48B
- View SIS Profile
- View Questions on SIS
- View Reports on SIS

Q: I am mostly content with my health care stocks with the exception of MDT. It has been essentially flat since about 2016 except for the dividend. It did peak around 2022 but has fallen down to previous levels.
What do you think of the longer term for MDT?
Would you make any other changes for slow but reliable growth and higher end of dividends.
As always, thank you for the great service.

Read Answer Asked by Tulio on August 21, 2025

Chevron Corporation (CVX $157.31)
- $157.31 P/E (TTM): 20.22X Cap: $319.21B
- View CVX Profile
- View Questions on CVX
Johnson & Johnson (JNJ $177.40)
- $177.40 P/E (TTM): 19.04X Cap: $427.23B
- View JNJ Profile
- View Questions on JNJ
Lockheed Martin Corporation (LMT $473.25)
- $473.25 P/E (TTM): 26.46X Cap: $110.48B
- View LMT Profile
- View Questions on LMT
Merck & Company Inc. (MRK $81.02)
- $81.02 P/E (TTM): 12.77X Cap: $206.84B
- View MRK Profile
- View Questions on MRK
PepsiCo Inc. (PEP $140.64)
- $140.64 P/E (TTM): 26.14X Cap: $192.54B
- View PEP Profile
- View Questions on PEP
AT&T Inc. (T $29.62)
- $29.62 P/E (TTM): 16.8X Cap: $211.79B
- View T Profile
- View Questions on T
Verizon Communications Inc. (VZ $43.87)
- $43.87 P/E (TTM): 10.25X Cap: $184.97B
- View VZ Profile
- View Questions on VZ

Q: Good Morning,

I am a retired income investor who recently received a small $40k USD inheritance.
I would like to purchase US dividend paying equities (for geographic exposure) but am concerned about the withholding tax.

Is there any vehicle available to avoid or lessen the tax? I have no room in my registered account.

What are you highest conviction US stocks with plus 4% yield and some growth potential.?

Thanks Dave

Read Answer Asked by Dave on August 12, 2025

Gilead Sciences Inc. (GILD $112.54)
- $112.54 P/E (TTM): 22.77X Cap: $141.15B
- View GILD Profile
- View Questions on GILD
Intuitive Surgical Inc. (ISRG $433.99)
- $433.99 P/E (TTM): 62.63X Cap: $161.19B
- View ISRG Profile
- View Questions on ISRG
AbbVie Inc. (ABBV $217.61)
- $217.61 P/E (TTM): 104.47X Cap: $385.71B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $177.40)
- $177.40 P/E (TTM): 19.04X Cap: $427.23B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $748.19)
- $748.19 P/E (TTM): 49.37X Cap: $708.12B
- View LLY Profile
- View Questions on LLY
Medtronic plc. (MDT $93.43)
- $93.43 P/E (TTM): 26.05X Cap: $119.84B
- View MDT Profile
- View Questions on MDT
Stryker Corporation (SYK $377.11)
- $377.11 P/E (TTM): 50.77X Cap: $146.55B
- View SYK Profile
- View Questions on SYK
Thermo Fisher Scientific Inc (TMO $474.46)
- $474.46 P/E (TTM): 27.73X Cap: $179.16B
- View TMO Profile
- View Questions on TMO
Health Care Select Sector SPDR (XLV $136.93)
- $136.93 P/E (TTM): 23.54X Cap: $34.36B
- View XLV Profile
- View Questions on XLV
iShares U.S. Medical Devices ETF (IHI $60.34)
- $60.34 P/E (TTM): 28.37X Cap: $4.26B
- View IHI Profile
- View Questions on IHI
Sabra Health Care REIT Inc. (SBRA $19.19)
- $19.19 P/E (TTM): 24.74X Cap: $4.56B
- View SBRA Profile
- View Questions on SBRA
Healthcare Realty Trust Incorporated (HR $18.07)
- $18.07 Cap: $6.44B
- View HR Profile
- View Questions on HR
iShares U.S. Pharmaceuticals ETF (IHE $70.21)
- $70.21 P/E (TTM): 19.44X Cap: $577M
- View IHE Profile
- View Questions on IHE
Catalyst Pharmaceuticals Inc. (CPRX $19.76)
- $19.76 P/E (TTM): 12.1X Cap: $2.44B
- View CPRX Profile
- View Questions on CPRX

Q: There was an article in the Globe and Mail today by David Rosenberg about the aging population and he suggested health care related investments such as health care REITS, pharma, devices, and services. What do you think of this idea and can you give me a few recommendations in canada and the US for each of the 4 categories (health reits, pharma, devices, sefrvices)? A mix of ETFS and individual stocks would be great.

Read Answer Asked by Carla on July 08, 2025